Regulatory Status AOD-9604 is not FDA-approved for any medical use and is listed by the FDA as a bulk drug substance that may present safety risks. Clinical development was halted after Phase IIb trials failed to meet efficacy endpoints. Summary AOD-9604 is a synthetic analog of the HGH 177191 fragment developed for fat-metabolism research
Improper preparation can compromise drug efficacy and patient safety
Others had just placed orders that would never arrive
Diagnosis of B12 deficiency typically involves blood tests including a full blood count, serum B12 and folate levels
The inclusion of this compound in research protocols introduces a potent variable for investigating anti-inflammatory signaling and the prevention of muscle catabolism at the cellular level
Vitaject injection also used as an adjuvant in the treatment of infectious disease, therapy against sterility, stress (weaning, transport, vaccination, errors in feeding) and diarrhea